About me
Miriam Corredor is CEO of NoctuRNA Therapeutics, a biotech company developing novel circular RNA therapeutics for neurodegenerative, neuromuscular and infectious diseases. She holds a PhD in Medicinal Chemistry in neurodegenerative diseases and a Master’s in Business Innovation, with over 10 years of experience in translational research and innovation management. Before founding NoctuRNA in 2022, she worked at CSIC and Fundación Leitat, building expertise at the intersection of science, innovation, and entrepreneurship.
